These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 26768420

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The Role of Routine Peritoneal and Omental Biopsies at Risk-Reducing Salpingo-Oophorectomy.
    Miller H, Pipkin LS, Tung C, Hall TR, Masand RP, Anderson ML.
    J Minim Invasive Gynecol; 2017; 24(5):772-776. PubMed ID: 28285055
    [Abstract] [Full Text] [Related]

  • 3. Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol.
    Rabban JT, Krasik E, Chen LM, Powell CB, Crawford B, Zaloudek CJ.
    Am J Surg Pathol; 2009 Dec; 33(12):1878-85. PubMed ID: 19898224
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
    Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B, Murphy J, Ghadirian P, Friedman E, Foulkes WD, Kim-Sing C, Wagner T, Tung N, Couch F, Stoppa-Lyonnet D, Ainsworth P, Daly M, Pasini B, Gershoni-Baruch R, Eng C, Olopade OI, McLennan J, Karlan B, Weitzel J, Sun P, Narod SA, Hereditary Ovarian Cancer Clinical Study Group.
    JAMA; 2006 Jul 12; 296(2):185-92. PubMed ID: 16835424
    [Abstract] [Full Text] [Related]

  • 8. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT, Barnes M, Chen LM, Powell CB, Crawford B, Zaloudek CJ.
    Am J Surg Pathol; 2009 Aug 12; 33(8):1125-36. PubMed ID: 19440148
    [Abstract] [Full Text] [Related]

  • 9. Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.
    Yates MS, Meyer LA, Deavers MT, Daniels MS, Keeler ER, Mok SC, Gershenson DM, Lu KH.
    Cancer Prev Res (Phila); 2011 Mar 12; 4(3):463-70. PubMed ID: 21278312
    [Abstract] [Full Text] [Related]

  • 10. The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy.
    van der Aa JE, Hoogendam JP, Butter ES, Ausems MG, Verheijen RH, Zweemer RP.
    Fam Cancer; 2015 Dec 12; 14(4):539-44. PubMed ID: 26264902
    [Abstract] [Full Text] [Related]

  • 11. Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility.
    Landon G, Stewart J, Deavers M, Lu K, Sneige N.
    Gynecol Oncol; 2012 Jun 12; 125(3):683-6. PubMed ID: 22425664
    [Abstract] [Full Text] [Related]

  • 12. Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.
    Olivier RI, van Beurden M, Lubsen MA, Rookus MA, Mooij TM, van de Vijver MJ, van't Veer LJ.
    Br J Cancer; 2004 Apr 19; 90(8):1492-7. PubMed ID: 15083174
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of risk-reducing salpingo-oophorectomy in patients with BRCA1/2 mutation.
    Abay M, Ozgen L, Yalcin Y, Ozerkan K.
    J Gynecol Obstet Hum Reprod; 2023 Oct 19; 52(8):102642. PubMed ID: 37573025
    [Abstract] [Full Text] [Related]

  • 14. Quantitative analysis of γ-H2AX and p53 nuclear expression levels in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies in BRCA1 and BRCA2 mutation carriers.
    Staff S, Tolonen T, Laasanen SL, Mecklin JP, Isola J, Mäenpää J.
    Int J Gynecol Pathol; 2014 May 19; 33(3):309-16. PubMed ID: 24681744
    [Abstract] [Full Text] [Related]

  • 15. The prevalence of occult ovarian cancer in the series of 155 consequently operated high risk asymptomatic patients - Slovenian population based study.
    Gornjec A, Merlo S, Novakovic S, Stegel V, Gazic B, Perhavec A, Blatnik A, Krajc M.
    Radiol Oncol; 2020 May 28; 54(2):180-186. PubMed ID: 32463390
    [Abstract] [Full Text] [Related]

  • 16. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.
    Powell CB, Kenley E, Chen LM, Crawford B, McLennan J, Zaloudek C, Komaromy M, Beattie M, Ziegler J.
    J Clin Oncol; 2005 Jan 01; 23(1):127-32. PubMed ID: 15625367
    [Abstract] [Full Text] [Related]

  • 17. Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: A large prospective single institution experience.
    Rush SK, Swisher EM, Garcia RL, Pennington KP, Agnew KJ, Kilgore MR, Norquist BM.
    Gynecol Oncol; 2020 May 01; 157(2):514-520. PubMed ID: 32199636
    [Abstract] [Full Text] [Related]

  • 18. Risk reducing surgery with peritoneal staging in BRCA1-2 mutation carriers. A prospective study.
    Marchetti C, Arcieri M, Vertechy L, Ergasti R, Russo G, Zannoni GF, Minucci A, Ercoli A, Scambia G, Fagotti A.
    Eur J Surg Oncol; 2022 Dec 01; 48(12):2539-2544. PubMed ID: 35871032
    [Abstract] [Full Text] [Related]

  • 19. Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer.
    Nomura H, Ikki A, Fusegi A, Omi M, Aoki Y, Netsu S, Tanigawa T, Matoda M, Okamoto S, Omatsu K, Nakajima T, Ueki A, Tonooka A, Kanao H.
    Int J Clin Oncol; 2021 Dec 01; 26(12):2331-2337. PubMed ID: 34453642
    [Abstract] [Full Text] [Related]

  • 20. The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer.
    Manchanda R, Drapkin R, Jacobs I, Menon U.
    Gynecol Oncol; 2012 Feb 01; 124(2):185-91. PubMed ID: 22019526
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.